"Hemophilia A" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage.
| Descriptor ID |
D006467
|
| MeSH Number(s) |
C15.378.100.100.500 C15.378.100.141.500 C15.378.463.500 C16.320.099.500
|
| Concept/Terms |
Hemophilia A- Hemophilia A
- Hemophilia As
- Hemophilia, Classic
- Hemophilia
- Hemophilia A, Congenital
- Congenital Hemophilia A
- Congenital Hemophilia As
- Hemophilia As, Congenital
- Classic Hemophilia
- Classic Hemophilias
- Hemophilias, Classic
- Haemophilia
Autosomal Hemophilia A- Autosomal Hemophilia A
- As, Autosomal Hemophilia
- Autosomal Hemophilia As
- Hemophilia A, Autosomal
- Hemophilia As, Autosomal
Factor VIII Deficiency- Factor VIII Deficiency
- Factor 8 Deficiency, Congenital
- Factor VIII Deficiency, Congenital
- Deficiency, Factor VIII
|
Below are MeSH descriptors whose meaning is more general than "Hemophilia A".
Below are MeSH descriptors whose meaning is more specific than "Hemophilia A".
This graph shows the total number of publications written about "Hemophilia A" by people in this website by year, and whether "Hemophilia A" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2017 | 2 | 0 | 2 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hemophilia A" by people in Profiles.
-
Analysis of College of American Pathologists von Willebrand Factor Proficiency Testing Program. Semin Thromb Hemost. 2022 Sep; 48(6):690-699.
-
Hemophilia Liver Transplantation Observational Study. Liver Transpl. 2017 06; 23(6):762-768.
-
Therapeutic plasma exchange as part of multimodal treatment of acquired hemophilia in a patient with concurrent acute intracerebral bleed and pulmonary embolism. Transfusion. 2017 07; 57(7):1827-1832.
-
Postauthorization safety surveillance of ADVATE [antihaemophilic factor (recombinant), plasma/albumin-free method] demonstrates efficacy, safety and low-risk for immunogenicity in routine clinical practice. Haemophilia. 2010 Nov; 16(6):866-77.
-
Ethical issues in haemophilia. Haemophilia. 2006 Jul; 12 Suppl 3:30-5.
-
Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma. Crit Care. 2005; 9 Suppl 5:S37-42.
-
Acquired factor VIII inhibitor presenting as a tongue hematoma. J Emerg Med. 2004 May; 26(4):411-4.
-
Acquired hemophilia A after liver transplantation: a case report. Liver Transpl. 2003 May; 9(5):523-6.
-
Risk factors for infection with HBV and HCV in a largecohort of hemophiliac males. Transfusion. 2001 Mar; 41(3):338-43.
-
Risk of hepatitis A virus infection in persons with hemophilia receiving plasma-derived products. Transfus Med Rev. 2000 Jan; 14(1):64-73.